 The aim of this study was to compare the performances pretargeted immunoPET Hepatic tumor burden following intra-portal injection of luciferase-transfected LS174T cells in nude mice was confirmed using bioluminescence. One group of animals was injected intravenously with TF2 and with Tumor/organ ratios were significantly higher with None